New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones

• 来源期刊: 亚洲男性学杂志（英文版）
• 年，卷（期）: 2015,（6）
• 页码范围: 925-928
• 页数: 4页
• 语种: 中文
• DOI: 10.4103/1008-682X.152819

摘要

Itis a pleasure to contribute our presentation at the International Prostate Forum of theAnnual Meeting of the American Urological Association (AUA) to this special issue of the Asian Journal of Andrology. We are gratified that the method developed in our laboratories1 based on agonistic analogs of hypothalamic luteinizing hormone-releasing hormone (LHRH), also called gonadotropin-releasing hormone, which was discovered and characterized by one of us (AVS) in the 1970s,2-6 has been used since the early 1980s for the treatment of hormone-dependent prostate cancer.